Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics [Phase 1]
First-in-human Phase 1 study of AUR 103 Calcium to evaluate safety, pharmacokinetics, and pharmacodynamics in adults with acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: First in Human, Dose Escalation, Dose Expansion Study of AUR105 [Phase 1]
AUR105 is Aurigene's first-in-human Phase 1 study with dose-escalation and dose-expansion cohorts in adults with solid tumors and lymphomas.…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers [Phase 1]
This is a Phase 1 clinical trial update for LY4584180 in adults with previously treated blood cancers, including Non-Hodgkin lymphoma, diffu…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial update for BGB-16673, a BTK-targeted protein degrader, in Chinese participants with various B-cell malignan…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating Rondecabtagene Autoleucel for aggressive large B-cell lymphoma in patients with relapsed or refractory Non-Hodg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL [Phase 1, Phase 2]
This clinical trial update describes sequential IOMAB-CAR-T followed by CAR-T cell therapy for relapsed/refractory diffuse large B-cell lymp…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Pre-malignant States to Hematologic Malignancies in Firefighters
A Wake Forest trial investigates progression from pre-malignant hematologic states to blood cancers in firefighters and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a two-step reduced-intensity conditioning approach for bone marrow transplant in adults with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors [NA]
This completed clinical trial evaluated the effectiveness and implementation of an electronic health record tool to assess heart health amon…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients [Phase 2]
Phase II clinical trial evaluating the combination of pirtobrutinib with venetoclax in relapsed/refractory mantle cell lymphoma is currently…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy [NA]
This clinical trial update describes a study exploring voice as a way to monitor side effects in people receiving CAR T-cell therapy, includ…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating CD45RA-depleted stem cell addback to prevent viral or fungal infections following TCRab/CD19-deplet…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial evaluating TriCAR19.20.22 T cells, a CD19/20/22-targeting CAR-T therapy, for relapsed or refractory non-Hodgkin lymphoma, acut…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) [Phase 2]
Phase 2 update from the Pediatric MATCH trial describes targeted therapies matched to tumor genetics in pediatric patients with relapsed or …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update. It evaluates a conditioning strategy using chemotherapy, total body irradiation, and post-transpl…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating CAR-T cell therapy for HIV-infected individuals with AIDS-related and other B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: SynKIR-310 for Relapsed/Refractory B-NHL [Phase 1]
Phase 1 trial update for SynKIR-310 in relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial of IPH6501 in relapsed/refractory B-cell non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BMS-986458 alone and in combination with anti-lymphoma agents for relapsed or refractory Non-Hodgkin l…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma [Phase 2]
A Phase 2 trial is evaluating an Ibrutinib-based combination therapy for newly diagnosed primary central nervous system lymphoma in transpla…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy, safety, and pharmacokinetics of XEMBIFY plus standard medical treatment (SMT) versus pl…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial update for constitutive IL7R (C7R) modified banked allogeneic CD30.CAR EBVSTs in CD30-positive lymphomas, currently r…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Studying TAK-243 in Patients With Advanced Cancer [Phase 1]
This entry describes a Phase 1 clinical trial evaluating TAK-243 in adults with advanced cancers, including non-Hodgkin lymphoma and various…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This document provides a status update on a Phase 1/2 clinical trial evaluating JNJ-90014496 in participants with B-cell non-Hodgkin lymphom…